title: wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila.
abstract: We conducted a large-scale screen for Drosophila mutants that have structural abnormalities of the larval neuromuscular junction (NMJ). We recovered mutations in wishful thinking (wit), a gene that positively regulates synaptic growth. wit encodes a BMP type II receptor. In wit mutant larvae, the size of the NMJs is greatly reduced relative to the size of the muscles. wit NMJs have reduced evoked excitatory junctional potentials, decreased levels of the synaptic cell adhesion molecule Fasciclin II, and synaptic membrane detachment at active zones. Wit is expressed by a subset of neurons, including motoneurons. The NMJ phenotype is specifically rescued by transgenic expression of Wit only in motoneurons. Thus, Wit appears to function as a presynaptic receptor that regulates synaptic size at the Drosophila NMJ.
authors.affiliation: Howard Hughes Medical Institute, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.
authors.forename: Hermann
authors.initials: H
authors.lastname: Aberle
authors.forename: A Pejmun
authors.initials: AP
authors.lastname: Haghighi
authors.forename: Richard D
authors.initials: RD
authors.lastname: Fetter
authors.forename: Brian D
authors.initials: BD
authors.lastname: McCabe
authors.forename: Tiago R
authors.initials: TR
authors.lastname: Magalhães
authors.forename: Corey S
authors.initials: CS
authors.lastname: Goodman
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified / Q000002:abnormalities / Q000254:growth & development / Q000378:metabolism; D019521:Body Patterning / Q000235:genetics*; D052006:Bone Morphogenetic Protein Receptors, Type II; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism; D002448:Cell Adhesion / Q000235:genetics; D002490:Central Nervous System / Q000002:abnormalities* / Q000254:growth & development / Q000648:ultrastructure; D015536:Down-Regulation / Q000235:genetics; D029721:Drosophila Proteins / Q000235:genetics* / Q000302:isolation & purification; D004331:Drosophila melanogaster / Q000196:embryology* / Q000254:growth & development / Q000648:ultrastructure; D004546:Elapid Venoms / Q000378:metabolism; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000502:physiology*; D005820:Genetic Testing; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D009469:Neuromuscular Junction / Q000002:abnormalities* / Q000254:growth & development / Q000648:ultrastructure; D009473:Neuronal Plasticity / Q000235:genetics; D018377:Neurotransmitter Agents / Q000235:genetics / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000235:genetics* / Q000302:isolation & purification; D017386:Sequence Homology, Amino Acid; D012689:Sequence Homology, Nucleic Acid; D015398:Signal Transduction / Q000235:genetics; D013570:Synaptic Membranes / Q000235:genetics / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D019485:Bone Morphogenetic Proteins; D029721:Drosophila Proteins; D004546:Elapid Venoms; D018377:Neurotransmitter Agents; C044937:fasciculin; D017346:Protein Serine-Threonine Kinases; D052006:Bone Morphogenetic Protein Receptors, Type II